These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20493430)

  • 41. Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1-2 hypertension.
    White WB; Davidai G; Schumacher H
    J Hum Hypertens; 2009 Dec; 23(12):817-25. PubMed ID: 19357698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative effects of telmisartan and valsartan as add-on agents for hypertensive patients with morning blood pressure insufficiently controlled by amlodipine monotherapy.
    Yoshida H; Akasaka H; Saitoh S; Shimamoto K; Miura T;
    Hypertens Res; 2014 Mar; 37(3):225-31. PubMed ID: 24108237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations of insulin resistance and the serum adiponectin level in patients with type 2 diabetes mellitus under the usual antihypertensive dosage of telmisartan treatment.
    Fuke Y; Fujita T; Satomura A; Wada Y; Matsumoto K
    Diabetes Technol Ther; 2010 May; 12(5):393-8. PubMed ID: 20388049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.
    Younis F; Stern N; Limor R; Oron Y; Zangen S; Rosenthal T
    Metabolism; 2010 Aug; 59(8):1200-9. PubMed ID: 20070992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Titration of telmisartan, but not addition of amlodipine, reduces urine albumin in diabetic patients treated with telmisartan-diuretic.
    Kojima M; Ohashi M; Dohi Y; Kimura G
    J Hypertens; 2013 Jan; 31(1):186-91. PubMed ID: 23047595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of combination therapy with telmisartan plus amlodipine in patients with poorly controlled hypertension.
    Bekki H; Yamamoto K; Sone M; Homma T; Nakata M; Nohara M; Fukami K; Okuda S; Yamagishi S
    Oxid Med Cell Longev; 2010; 3(5):342-6. PubMed ID: 21150340
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of telmisartan on forearm postischemic hyperemia and serum asymmetric dimethylarginine levels.
    Tomiyama H; Yamada J; Koji Y; Shiina K; Yoshida M; Yamashina A
    Am J Hypertens; 2007 Dec; 20(12):1305-11. PubMed ID: 18047921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood pressure-lowering and antiproteinuric effect of switching from high-dose angiotensin receptor blockers to normal-dose telmisartan and low-dose hydrochlorothiazide in hypertensive patients with chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto S; Matsumoto K
    Int J Clin Pharmacol Ther; 2010 Mar; 48(3):206-13. PubMed ID: 20197015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of telmisartan vs. valsartan in the treatment of mild to moderate hypertension using ambulatory blood pressure monitoring.
    Bakris G
    J Clin Hypertens (Greenwich); 2002; 4(4 Suppl 1):26-31. PubMed ID: 12147926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Difference in the effects of switching from candesartan to olmesartan or telmisartan to olmesartan in hypertensive patients with type 2 diabetes: the COTO study.
    Daikuhara H; Fukunaga K; Ohshima T
    Drug Des Devel Ther; 2014; 8():219-26. PubMed ID: 24600204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
    Rizos CV; Milionis HJ; Kostapanos MS; Florentin M; Kostara CE; Elisaf MS; Liberopoulos EN
    Clin Ther; 2010 Mar; 32(3):492-505. PubMed ID: 20399986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome.
    Kishi T; Hirooka Y; Konno S; Sunagawa K
    J Hypertens; 2012 Aug; 30(8):1646-55. PubMed ID: 22728908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control.
    Yamana A; Arita M; Furuta M; Shimajiri Y; Sanke T
    Diabetes Res Clin Pract; 2008 Oct; 82(1):127-31. PubMed ID: 18692932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension.
    Benndorf RA; Rudolph T; Appel D; Schwedhelm E; Maas R; Schulze F; Silberhorn E; Böger RH
    Metabolism; 2006 Sep; 55(9):1159-64. PubMed ID: 16919533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome.
    Khan AH; Imig JD
    Am J Hypertens; 2011 Jul; 24(7):816-21. PubMed ID: 21415842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-dose candesartan cilexetil prevents early kidney damage in type 2 diabetic patients with mildly elevated blood pressure.
    Murayama S; Hirano T; Sakaue T; Okada K; Ikejiri R; Adachi M
    Hypertens Res; 2003 Jun; 26(6):453-8. PubMed ID: 12862201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patients.
    Aoki A; Ogawa T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Nitta K
    Heart Vessels; 2010 May; 25(3):195-202. PubMed ID: 20512446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of the angiotensin II receptor blockers telmisartan vs valsartan in combination with hydrochlorothiazide 25 mg once daily for the treatment of hypertension.
    White WB; Punzi HA; Murwin D; Koval SE; Davidai G; Neutel JM
    J Clin Hypertens (Greenwich); 2006 Sep; 8(9):626-33. PubMed ID: 16957424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of AT1 receptor blockade on blood pressure, renal haemodynamics and hormonal responses to intravenous angiotensin II infusion in hypertensive patients.
    Fridman KU; Elmfeldt D; Wysocki M; Friberg PR; Andersson OK
    Blood Press; 2002; 11(4):244-52. PubMed ID: 12361194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy.
    Hinoi T; Tomohiro Y; Kajiwara S; Matsuo S; Fujimoto Y; Yamamoto S; Shichijo T; Ono T
    Hypertens Res; 2008 Apr; 31(4):615-22. PubMed ID: 18633172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.